Anti-allergic pharmaceutical composition for ophthalmic topical administration
AssigneesTaiho Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd.
InventorsHitoshi Ohmori, Takahiro Ogawa, Fuminori Tokumochi, Atsushi Okumura
Life of this patent
Estimating the term…
Abstract
The present invention provides an anti-allergic pharmaceutical composition for ophthalmic topical administration comprising an IgE antibody production inhibitor as an active ingredient. The present invention also provides a process for producing an anti-allergic pharmaceutical composition for ophthalmic topical administration, which comprises mixing an IgE antibody production inhibitor with a pharmaceutically acceptable carrier, excipient or diluent.
Claims8
A method of treating an allergic disease in mammals which comprises topically administering to an eye of a subject in need thereof an effective amount of an IgE antibody production inhibitor compound of the following formula:
- ##STR2##
Dependencies are inferred from the claim text.